Preface

Bacterial infections remain a large and growing worldwide problem as healthcare services continue to be challenged by ongoing changes in the types of organisms causing infections, the increase in resistance of organisms to antibiotics, and the fact that not all patients have equal access to available therapies for treating bacterial infections. While advances have been made in developing better methods for diagnosing and treating bacterial infections, due to the ongoing threat posed by drug-resistant bacteria, new integrated sustainability strategies are required. part II of Diagnosis and Treatment of Bacterial Infections looks at current challenges in diagnosing and treating bacterial infections from an innovative and integrated perspective by exploring new scientific information and new technologies that are changing the way we view and conduct antibacterial research and clinical practice.

This part expands beyond conventional therapeutic paradigms by integrating culturally acquired knowledge with modern medicine's scientific method. The review of phytotherapy demonstrates how certain natural products have the potential of being useful as either adjunctive or alternative antibacterials. At the same time, the use of immunomodulatory techniques is presented as a potential means to improve or enhance the host's ability to counteract infections through enhanced immune responses, allowing us to focus our attention away from only treating infections and towards enhancing the host's ability to protect itself.

Recent advances in genetics and molecular biology have led to the development of new infection control strategies. The chapters that focus specifically on CRISPR-Cas and other gene editing technologies are especially relevant because they offer potential for precisely targeting disease-causing bacteria and treating multidrug-resistant (MDR) organisms, commonly referred to as "superbugs." This book also takes a holistic view of managing bacterial infections, looking at everything from diagnostic testing to successful treatment, with an emphasis on the potential for developing interdisciplinary and emerging technologies.

This book also takes into account the effects of digital innovations, including artificial intelligence (AI), on the future of antibiotic stewardship. This part will evaluate how AI can improve the effectiveness and applicability of antibiotic stewardship tools like clinical decision support systems (CDSs) and reduce the inappropriate use of antibiotics.

In addition to addressing the technology aspects of the diagnosis and treatment of bacterial infections, this second part will examine both the economic and accessibility-related challenges that are posed by bacterial resistance to antibiotics and the need for equitable healthcare strategies and government-sponsored programs, particularly in low-income areas.

This second part of Diagnosis and Treatment of Bacterial Infections is intended for clinicians, researchers in the field, pharmacy scientists, and policymakers. By connecting traditional treatments with emerging technological advances and digital health innovations, this part seeks to meaningfully contribute to global efforts to combat bacterial infections and reduce the impact of antibiotic resistance.